Akros Pharma Inc.

Address: 302 Carnegie Center Suite 300

Sponsor Overview

assignment

Specializations

Gastrointestinal Disorders and Functional Bowel Conditions

The sponsor maintains a dedicated focus on addressing disorders of the digestive system, with particular emphasis on conditions affecting bowel function and gastrointestinal motility. Research efforts concentrate on therapeutic interventions for patients experiencing chronic digestive disturbances that significantly impact quality of life and daily functioning.

Chronic Idiopathic Constipation
Functional Gastrointestinal Disorders
Bowel Movement Regulation

The clinical research portfolio reflects a commitment to developing treatments that address the underlying mechanisms of intestinal dysfunction, targeting patient populations who struggle with persistent digestive symptoms. The therapeutic approach encompasses understanding the complex interplay between gut physiology and symptom manifestation in chronic conditions.

Quality of Life and Patient-Centered Outcomes

A significant component of the research framework involves comprehensive assessment of how gastrointestinal conditions affect patients' overall wellbeing and daily activities. The sponsor prioritizes measuring therapeutic impact through patient-reported outcomes and functional status improvements.

Symptom Burden Assessment
Daily Function Restoration
Treatment Satisfaction Evaluation

The clinical investigation strategy incorporates validated instruments to capture changes in abdominal discomfort, bowel habit normalization, and overall symptom relief. This patient-centric approach ensures that therapeutic benefits align with meaningful improvements in everyday life for individuals managing chronic digestive conditions.

Trial Name	Country	Status
Efficacy, Safety, and Tolerability of JTT-861 in Heart Failure with Reduced Ejection Fraction: A Phase 2a Randomized, Double-blind, Placebo-controlled Study	Bulgaria Czechia Poland Romania Spain	Not Recruiting